uniQure NV
uniQure NV (QURE) Implied Volatility Current
QURE implied volatility is 147%. IV Rank is 72%, placing current premiums in the top of their 52-week range.
Read more
Tracking QURE implied volatility helps you identify when options premiums on uniQure NV are historically cheap or expensive, and where the best trades are hiding. uniQure NV implied volatility reflects the market's expectation of future price movement: when QURE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor uniQure NV's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For QURE, tracking metrics like QURE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on QURE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis.
uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where QURE implied volatility sits today versus where it has been. Our scanner ranks uniQure NV implied volatility against its historical range, surfaces extremes in QURE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether uniQure NV IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is slightly elevated - premiums are richer, leaning toward sellers.
As of September 25, 2026
Trade options with IV on your side
Track QURE IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→